Resolute Science

Website

Resolute Science, Inc.

9 Investors
Biotechnology - Oncology Therapeutics
San Diego, CA

Resolute Science, Inc. is a biotechnology company dedicated to advancing cancer treatment through innovative therapeutic strategies. The company specializes in addressing the challenges of solid tumor cancers, with a focus on overcoming recurrence and drug resistance.

Products & Team

MAC-TAC Platform

Cancer TherapeuticsSeed

The MAC-TAC platform is a groundbreaking technology in cancer therapeutics, specifically designed to harness Tumor-Associated Macrophages. These macrophages are used to transport cytotoxic agents directly to tumors, providing a targeted, robust attack on cancer cells.

Value Proposition

The MAC-TAC platform addresses the critical issue of cancer recurrence and drug resistance by employing a unique targeting strategy that enhances the effectiveness of treatments across various cancer types.

Pain Points

Addresses the need for more effective treatments that can prevent cancer recurrence and overcome drug resistance.

Leverages Tumor-Associated MacrophagesDelivers cytotoxic payloads directly to tumorsOffers an alternative to traditional cancer cell targeting
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
San Diego, CA
Primary headquarters

Funding History

Total Raised:
$1.4M
E

Debt Financing, Security Offering

February 2025
$3.0M
Target
Progress
45%
Raised
$1.4M
Target
$3.0M
#000202363825000001